chr1-17249187-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016233.2(PADI3):c.50C>T(p.Ala17Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016233.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI3 | NM_016233.2 | c.50C>T | p.Ala17Val | missense_variant | 1/16 | ENST00000375460.3 | NP_057317.2 | |
PADI3 | XM_011541572.3 | c.50C>T | p.Ala17Val | missense_variant | 1/12 | XP_011539874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PADI3 | ENST00000375460.3 | c.50C>T | p.Ala17Val | missense_variant | 1/16 | 1 | NM_016233.2 | ENSP00000364609 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000179 AC: 45AN: 251472Hom.: 0 AF XY: 0.000235 AC XY: 32AN XY: 135910
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461864Hom.: 0 Cov.: 30 AF XY: 0.000114 AC XY: 83AN XY: 727238
GnomAD4 genome AF: 0.000105 AC: 16AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74288
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.50C>T (p.A17V) alteration is located in exon 1 (coding exon 1) of the PADI3 gene. This alteration results from a C to T substitution at nucleotide position 50, causing the alanine (A) at amino acid position 17 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at